Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Long

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|February 2, 2021
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severityHamid Bolouri, Cate Speake, David Skibinski, et al.
Plos One|December 31, 2013
Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patientsKaren Cerosaletti, Anya Schneider, Katharine Schwedhelm, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 DiabetesAna Lledo Delgado, Paula Preston-Hurlburt, Noha Lim, et al.
Hepatology (Baltimore, Md.)|May 1, 2002
The SJL/J mouse is not a model for PBCMotoko Sasaki, S Alice Long, Judy Van De Water, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2011
Low-dose antigen promotes induction of FOXP3 in human CD4+ T cellsS Alice Long, Mary Rieck, Megan Tatum, et al.
Science Translational Medicine|May 8, 2024
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetesChristine Bender, Alice E Wiedeman, Alex Hu, et al.
Arthritis and Rheumatism|February 2, 2008
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alphaMichael J Elliot, Ravinder N Maini, Marc Feldmann, et al.
European Journal of Immunology|January 31, 2009
Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjectsS Alice Long, Mindi R Walker, Mary Rieck, et al.
Diabetes|June 22, 2019
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent AdvancesSimi Ahmed, Karen Cerosaletti, Eddie James, et al.
Science Immunology|July 1, 2017
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetesS Alice Long, Jerill Thorpe, Hannah A DeBerg, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|February 2, 2021
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severityHamid Bolouri, Cate Speake, David Skibinski, et al.
Plos One|December 31, 2013
Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patientsKaren Cerosaletti, Anya Schneider, Katharine Schwedhelm, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 DiabetesAna Lledo Delgado, Paula Preston-Hurlburt, Noha Lim, et al.
Hepatology (Baltimore, Md.)|May 1, 2002
The SJL/J mouse is not a model for PBCMotoko Sasaki, S Alice Long, Judy Van De Water, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2011
Low-dose antigen promotes induction of FOXP3 in human CD4+ T cellsS Alice Long, Mary Rieck, Megan Tatum, et al.
Science Translational Medicine|May 8, 2024
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetesChristine Bender, Alice E Wiedeman, Alex Hu, et al.
Arthritis and Rheumatism|February 2, 2008
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alphaMichael J Elliot, Ravinder N Maini, Marc Feldmann, et al.
European Journal of Immunology|January 31, 2009
Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjectsS Alice Long, Mindi R Walker, Mary Rieck, et al.
Diabetes|June 22, 2019
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent AdvancesSimi Ahmed, Karen Cerosaletti, Eddie James, et al.
Science Immunology|July 1, 2017
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetesS Alice Long, Jerill Thorpe, Hannah A DeBerg, et al.
Pageof 9